Applied Capital LLC FL grew its holdings in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 0.8% in the 2nd quarter, Holdings Channel.com reports. The firm owned 5,992 shares of the financial services provider’s stock after acquiring an additional 45 shares during the period. Applied Capital LLC FL’s holdings in CME Group were worth $1,652,000 as of its most recent SEC filing.
A number of other institutional investors have also recently made changes to their positions in the company. GQG Partners LLC increased its holdings in CME Group by 7,676.3% in the 1st quarter. GQG Partners LLC now owns 2,205,041 shares of the financial services provider’s stock worth $584,975,000 after acquiring an additional 2,176,685 shares in the last quarter. Wellington Management Group LLP grew its holdings in CME Group by 370.5% during the 1st quarter. Wellington Management Group LLP now owns 2,653,957 shares of the financial services provider’s stock valued at $704,068,000 after buying an additional 2,089,935 shares in the last quarter. Nuveen LLC purchased a new position in CME Group during the 1st quarter valued at approximately $218,842,000. Alliancebernstein L.P. grew its holdings in CME Group by 185.5% during the 1st quarter. Alliancebernstein L.P. now owns 1,244,608 shares of the financial services provider’s stock valued at $330,182,000 after buying an additional 808,740 shares in the last quarter. Finally, Egerton Capital UK LLP raised its position in CME Group by 79.4% during the first quarter. Egerton Capital UK LLP now owns 1,730,194 shares of the financial services provider’s stock valued at $459,003,000 after purchasing an additional 765,773 shares during the period. Hedge funds and other institutional investors own 87.75% of the company’s stock.
Analyst Upgrades and Downgrades
A number of equities research analysts have issued reports on CME shares. Citigroup upgraded CME Group from a “neutral” rating to a “buy” rating and upped their price objective for the company from $275.00 to $300.00 in a research report on Thursday, September 25th. TD Cowen raised their target price on shares of CME Group from $281.00 to $288.00 and gave the stock a “hold” rating in a research report on Wednesday. Piper Sandler increased their price objective on shares of CME Group from $283.00 to $296.00 and gave the company an “overweight” rating in a research note on Tuesday, July 15th. UBS Group cut their price objective on shares of CME Group from $305.00 to $285.00 and set a “neutral” rating on the stock in a research report on Monday, September 8th. Finally, Oppenheimer increased their target price on shares of CME Group from $300.00 to $303.00 and gave the company an “outperform” rating in a research report on Thursday, July 24th. Seven analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, CME Group currently has a consensus rating of “Hold” and an average price target of $281.00.
Insiders Place Their Bets
In other news, insider Sunil Cutinho sold 11,896 shares of the business’s stock in a transaction that occurred on Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total value of $3,229,407.12. Following the completion of the sale, the insider directly owned 17,440 shares in the company, valued at $4,734,436.80. The trade was a 40.55% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director William R. Shepard bought 262 shares of the firm’s stock in a transaction dated Thursday, September 25th. The stock was purchased at an average price of $265.19 per share, for a total transaction of $69,479.78. Following the transaction, the director owned 258,459 shares of the company’s stock, valued at approximately $68,540,742.21. This represents a 0.10% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have sold 13,043 shares of company stock valued at $3,527,956 over the last ninety days. 0.30% of the stock is owned by corporate insiders.
CME Group Price Performance
Shares of CME Group stock opened at $271.45 on Friday. The firm has a market cap of $97.83 billion, a PE ratio of 26.28, a P/E/G ratio of 5.67 and a beta of 0.41. CME Group Inc. has a twelve month low of $213.94 and a twelve month high of $290.79. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. The business has a 50-day moving average price of $268.89 and a 200 day moving average price of $271.17.
CME Group (NASDAQ:CME – Get Free Report) last posted its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, beating analysts’ consensus estimates of $2.91 by $0.05. The business had revenue of $1.69 billion during the quarter, compared to analysts’ expectations of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The business’s revenue was up 10.4% compared to the same quarter last year. During the same period in the previous year, the business earned $2.56 earnings per share. Sell-side analysts predict that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.
CME Group Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were given a $1.25 dividend. The ex-dividend date was Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.8%. CME Group’s payout ratio is 48.40%.
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Stories
- Five stocks we like better than CME Group
- What is the Australian Securities Exchange (ASX)
- 3 Heavily Shorted Stocks That Could Pop on Rate Cuts
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Broadcom Gets Second $420 Target as CPO Win Boosts Outlook
- High Flyers: 3 Natural Gas Stocks for March 2022
- PepsiCo’s Deep Discount Will Soon Evaporate: Buy It While You Can
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.